Please assess the completion status of the following clinical trial:

Trial Title: Intravenous Metoclopramide Versus Dexketoprofen Trometamol Versus Metoclopramide+ Dexketoprofen Trometamol in Migraine

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: None
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~-Patients aged 18 and over with acute headache who met the diagnostic criteria of the International Headache Association (9) for the diagnosis of migraine~Exclusion Criteria:~* Patients who refused to participate in the study~* Patients that took any analgesic medication within six hours before presentation to ED Patients with any additional organic pathology (e.g., hypertension, hypoglycemia, chronic kidney failure, and intracranial masses) pregnant women hemodynamically unstable patients patients with an allergy to the drugs used in the study

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 100 Years
- Healthy Volunteers: f

Study Arms:
- metoclopramide+ dexketoprofen trometamol (Type: ACTIVE_COMPARATOR): 10 mg metoclopramide+ 50 mg dexketoprofen trometamol
- metoclopramide (Type: EXPERIMENTAL): 10 mg metoclopramide
- dexketoprofen trometamol (Type: EXPERIMENTAL): 50 mg dexketoprofen trometamol

Based on this trial design, predict the completion outcome and termination type (if applicable).